7SZ-26474-93738 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-24
Dose 1 — Pfizer-BioNTech
2021-01-10
Registered in v-safe
2021-01-10
Dose 2 — Pfizer-BioNTech
2021-01-11
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-12
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Abdominal pain

Adult check-in
2021-01-13
Survey response — days 1–6 daily, dose 2
MedDRA: Rhinorrhoea — Feeling: Fair

Free text: Runny nose

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-17
Health check-in — day 7, dose 2
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-01-24
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-01-31
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-09
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-14
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-21
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-11
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-11
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-03
Dose 3 — Pfizer-BioNTech
2022-01-10
Survey response — 12 months, dose 2
MedDRA: Malaise, Rhinorrhoea — Feeling: Good · Be unable to work or attend school

Free text: Runny nose and malaise

MedDRA releases: 2024-11 · check-in free text available
2022-09-08
Dose 4 — Pfizer-BioNTech
Co-administered: Flu
2022-10-19
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2023-03-11
Survey response — 6 months, dose 4
MedDRA: Fatigue, Rhinorrhoea — Feeling: Fair

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-24	Pfizer-BioNTech
2	2021-01-10	Pfizer-BioNTech
3	2021-10-03	Pfizer-BioNTech	No
4	2022-09-08	Pfizer-BioNTech	Flu

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-13

Systemic reaction (other): Runny nose

Release 10 — 12 months, dose 2

2022-01-10

Symptoms: Runny nose and malaise

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Fatigue	·	·	✓
SD	Malaise	·	·	✓
SD	Rhinorrhoea	·	·	✓
SRO	Rhinorrhoea	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release